A special regulation applies in connection with the corona pandemic: Doctors are allowed to give sick leave to patients with mild diseases of the upper respiratory tract for a period of up to seven days after telephone consultation. The inability to work can be extended once for up to a further seven calendar days. The regulation applies until May 31, 2022.
STOP – do NOT come to the practice with an acute respiratory infection. Contact us via phone, mail or Patmed.
You can book an appointment during the consultation hours for acute illnesses online between 9 and 11 a.m. (Mon-Fri).
For the discussion of longer and less acute medical questions, please select the regular consultation options.
So-called “heterologous vaccination schemes” (mixing different vaccines) have already shown in some previous publications (so-called pre-prints) that better vaccination success can be achieved in this way, especially against the beta and delta variants.
All people whose basic immunization was 3 months ago can receive a booster vaccination.
Due to the insufficient vaccination protection at Johnson & Johnson, the STIKO recommends vaccinating again with an mRNA vaccine. This is considered an optimization of the Johnson & Johnson vaccination.
After another 3 months, the booster vaccination can be given as with Biontec / Modern.
There is no vaccination interval between COVID-19 vaccinations and the administration of other inactivated vaccines (e.g. flu vaccination, hepatitis A/B, tetanus, TBE). They can be given at the same time.
A minimum interval of 14 days before and after each COVID-19 vaccination should be maintained for vaccinations with live vaccines (mumps, measles, rubella, yellow fever).
In the case of severely immunodeficient persons with an expected severely reduced vaccination response (see Table 3), the 3rd vaccine dose can be administered as early as 4 weeks after the 2nd vaccine dose as an optimization of the primary vaccination series.
The timing of a booster vaccination after the primary vaccination series consisting of 3 vaccine doses must be decided on a case-by-case basis.
In the case of an expected severely reduced vaccination response, an antibody determination against SARS-CoV should be carried out at the earliest 4 weeks after the 2nd vaccine dose AND at the earliest 4 weeks after the 3rd vaccine dose
The booster vaccination should be administered no earlier than 3 months after the primary immunization (2 x mRNA or Johnson & Johnson + 1 x mRNA).
No booster vaccination is currently recommended for people who have undergone a laboratory-diagnosed SARS-CoV-2 infection after the COVID-19 vaccination. Corona disease is considered a booster.
In the case of people with HIV who have undergone a confirmed SARS-CoV-2 infection, it must be decided on a case-by-case basis whether a single vaccine dose is sufficient or whether a complete vaccination series should be administered. This largely depends on the type and severity of the immune deficiency.
A serological antibody test is not always recommended, since the value that means continued protection is not known and would therefore make a 3rd vaccine dose unnecessary and because there are no safety concerns with a 3rd vaccine dose.
The determination of the antibodies is not covered by health insurance.
For self-payers we offer the antibody test for 54.81 euros (medical services + laboratory service).
We offer you this service for 89 euros (including certificate) – result within 24 hours
A negative proof of SARS-CoV2 (molecular biological test – PCR) may be necessary in some cases, e.g. when traveling to an EU country or when entering Germany.